Report cover image

Global Amyotrophic Lateral Sclerosis Treatment Market 2025-2029

Publisher TechNavio
Published Aug 19, 2025
Length 217 Pages
SKU # INF20329136

Description

Amyotrophic Lateral Sclerosis Treatment Market 2025-2029

The amyotrophic lateral sclerosis treatment market is forecasted to grow by USD 207.5 mn during 2024-2029, accelerating at a CAGR of 4.8% during the forecast period. The report on the amyotrophic lateral sclerosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in incidence and prevalence of amyotrophic lateral sclerosis, huge unmet need for amyotrophic lateral sclerosis, and high research funding on amyotrophic lateral sclerosis treatment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's amyotrophic lateral sclerosis treatment market is segmented as below:

By Type
  • Intravenous
  • Oral
By Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
By Drug Class
  • Riluzole
  • Symptomatic treatments
  • Edaravone
  • Muscle relaxants
  • Antisense oligonucleotides
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in aging population as one of the prime reasons driving the amyotrophic lateral sclerosis treatment market growth during the next few years. Also, development of novel drugs for treatment of amyotrophic lateral sclerosis and rising funding in healthcare industry will lead to sizable demand in the market.

The report on the amyotrophic lateral sclerosis treatment market covers the following areas:
  • Amyotrophic Lateral Sclerosis Treatment Market sizing
  • Amyotrophic Lateral Sclerosis Treatment Market forecast
  • Amyotrophic Lateral Sclerosis Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amyotrophic lateral sclerosis treatment market vendors that include AB Science SA, Alkem Laboratories Ltd., Apotex Inc., Aquestive Therapeutics Inc, Biogen Inc., Brainstorm Cell Therapeutics Inc., CORESTEM Inc., Denali Therapeutics Inc., DR Reddys Laboratories Ltd., Eledon Pharmaceuticals, Ionis Pharmaceuticals Inc., Italfarmaco Holding SPA, Medindia Health, Mitsubishi Chemical Group Corp., Otsuka Holdings Co. Ltd., Revalesio Corp., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Treeway BV. Also, the amyotrophic lateral sclerosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

217 Pages
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Amyotrophic Lateral Sclerosis Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Amyotrophic Lateral Sclerosis Treatment Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Amyotrophic Lateral Sclerosis Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Intravenous - Market size and forecast 2024-2029
Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
Chart on Intravenous - Year-over-year growth 2024-2029 (%)
Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
8.4 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
10.3 Riluzole - Market size and forecast 2024-2029
Chart on Riluzole - Market size and forecast 2024-2029 ($ million)
Data Table on Riluzole - Market size and forecast 2024-2029 ($ million)
Chart on Riluzole - Year-over-year growth 2024-2029 (%)
Data Table on Riluzole - Year-over-year growth 2024-2029 (%)
10.4 Symptomatic treatments - Market size and forecast 2024-2029
Chart on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
Data Table on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
Chart on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
Data Table on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
10.5 Edaravone - Market size and forecast 2024-2029
Chart on Edaravone - Market size and forecast 2024-2029 ($ million)
Data Table on Edaravone - Market size and forecast 2024-2029 ($ million)
Chart on Edaravone - Year-over-year growth 2024-2029 (%)
Data Table on Edaravone - Year-over-year growth 2024-2029 (%)
10.6 Muscle relaxants - Market size and forecast 2024-2029
Chart on Muscle relaxants - Market size and forecast 2024-2029 ($ million)
Data Table on Muscle relaxants - Market size and forecast 2024-2029 ($ million)
Chart on Muscle relaxants - Year-over-year growth 2024-2029 (%)
Data Table on Muscle relaxants - Year-over-year growth 2024-2029 (%)
10.7 Antisense oligonucleotides - Market size and forecast 2024-2029
Chart on Antisense oligonucleotides - Market size and forecast 2024-2029 ($ million)
Data Table on Antisense oligonucleotides - Market size and forecast 2024-2029 ($ million)
Chart on Antisense oligonucleotides - Year-over-year growth 2024-2029 (%)
Data Table on Antisense oligonucleotides - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AB Science SA
AB Science SA - Overview
AB Science SA - Product / Service
AB Science SA - Key offerings
SWOT
15.5 Alkem Laboratories Ltd.
Alkem Laboratories Ltd. - Overview
Alkem Laboratories Ltd. - Business segments
Alkem Laboratories Ltd. - Key offerings
Alkem Laboratories Ltd. - Segment focus
SWOT
15.6 Aquestive Therapeutics Inc
Aquestive Therapeutics Inc - Overview
Aquestive Therapeutics Inc - Product / Service
Aquestive Therapeutics Inc - Key offerings
SWOT
15.7 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key offerings
SWOT
15.8 Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc. - Overview
Brainstorm Cell Therapeutics Inc. - Product / Service
Brainstorm Cell Therapeutics Inc. - Key offerings
SWOT
15.9 CORESTEM Inc.
CORESTEM Inc. - Overview
CORESTEM Inc. - Product / Service
CORESTEM Inc. - Key offerings
SWOT
15.10 Denali Therapeutics Inc.
Denali Therapeutics Inc. - Overview
Denali Therapeutics Inc. - Product / Service
Denali Therapeutics Inc. - Key offerings
SWOT
15.11 Eledon Pharmaceuticals
Eledon Pharmaceuticals - Overview
Eledon Pharmaceuticals - Product / Service
Eledon Pharmaceuticals - Key offerings
SWOT
15.12 Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc. - Overview
Ionis Pharmaceuticals Inc. - Product / Service
Ionis Pharmaceuticals Inc. - Key news
Ionis Pharmaceuticals Inc. - Key offerings
SWOT
15.13 Italfarmaco Holding SPA
Italfarmaco Holding SPA - Overview
Italfarmaco Holding SPA - Product / Service
Italfarmaco Holding SPA - Key offerings
SWOT
15.14 Mitsubishi Chemical Group Corp.
Mitsubishi Chemical Group Corp. - Overview
Mitsubishi Chemical Group Corp. - Business segments
Mitsubishi Chemical Group Corp. - Key news
Mitsubishi Chemical Group Corp. - Key offerings
Mitsubishi Chemical Group Corp. - Segment focus
SWOT
15.15 Revalesio Corp.
Revalesio Corp. - Overview
Revalesio Corp. - Product / Service
Revalesio Corp. - Key offerings
SWOT
15.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.17 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.18 Treeway BV
Treeway BV - Overview
Treeway BV - Product / Service
Treeway BV - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Amyotrophic Lateral Sclerosis Treatment Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Type - Market share 2024-2029 (%)
Exhibits39: Data Table on Type - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Type
Exhibits41: Data Table on Comparison by Type
Exhibits42: Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Intravenous - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Type ($ million)
Exhibits51: Data Table on Market opportunity by Type ($ million)
Exhibits52: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits53: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits68: Market opportunity by Distribution Channel ($ million)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits70: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits71: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits72: Chart on Comparison by Drug Class
Exhibits73: Data Table on Comparison by Drug Class
Exhibits74: Chart on Riluzole - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Riluzole - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Riluzole - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Riluzole - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Edaravone - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Edaravone - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Edaravone - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Edaravone - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Muscle relaxants - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Muscle relaxants - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Muscle relaxants - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Muscle relaxants - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Antisense oligonucleotides - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on Antisense oligonucleotides - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on Antisense oligonucleotides - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Antisense oligonucleotides - Year-over-year growth 2024-2029 (%)
Exhibits94: Market opportunity by Drug Class ($ million)
Exhibits95: Data Table on Market opportunity by Drug Class ($ million)
Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits99: Chart on Geographic comparison
Exhibits100: Data Table on Geographic comparison
Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on India - Market size and forecast 2024-2029 ($ million)

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.